Group One Trading, L.P. Lexicon Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.53 $16,054 - $24,562	16,054 New	16,054 $24,000
Q2 2023 Aug 09, 2023	BUY	$2.15 - $3.49 $128,677 - $208,876	59,850 Added 178.59%	93,363 $213,000
Q1 2023 May 12, 2023	BUY	$1.99 - $2.68 $18,485 - $24,894	9,289 Added 38.35%	33,513 $81,000
Q4 2022 Feb 09, 2023	SELL	$1.8 - $2.56 $189,086 - $268,922	-105,048 Reduced 81.26%	24,224 $46,000
Q3 2022 Nov 09, 2022	BUY	$1.94 - $3.43 $67,263 - $118,924	34,672 Added 36.65%	129,272 $310,000
Q2 2022 Aug 11, 2022	BUY	$1.31 - $2.69 $19,174 - $39,373	14,637 Added 18.3%	94,600 $176,000
Q1 2022 May 12, 2022	SELL	$1.95 - $3.89 $106,694 - $212,841	-54,715 Reduced 40.63%	79,963 $167,000
Q4 2021 Feb 11, 2022	BUY	$3.81 - $6.16 $450,742 - $728,758	118,305 Added 722.56%	134,678 $531,000
Q3 2021 Nov 12, 2021	SELL	$3.38 - $5.35 $68,309 - $108,123	-20,210 Reduced 55.24%	16,373 $79,000
Q2 2021 Aug 10, 2021	BUY	$4.12 - $5.87 $150,721 - $214,742	36,583 New	36,583 $168,000
Q1 2021 May 12, 2021	SELL	$3.45 - $9.09 $127,957 - $337,139	-37,089 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$1.05 - $3.67 $36,853 - $128,813	35,099 Added 1763.77%	37,089 $127,000
Q3 2020 Nov 12, 2020	BUY	$1.44 - $2.1 $2,865 - $4,179	1,990 New	1,990 $3,000
Q2 2020 Aug 13, 2020	SELL	$1.75 - $2.3 $16,325 - $21,456	-9,329 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.8 - $4.28 $16,792 - $39,928	9,329 New	9,329 $18,000
Q1 2019 May 13, 2019	SELL	$4.36 - $7.94 $12,142 - $22,112	-2,785 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$6.15 - $10.51 $17,127 - $29,270	2,785 New	2,785 $18,000
Q4 2017 Feb 09, 2018	SELL	$8.77 - $12.28 $614,706 - $860,729	-70,092 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$12.17 - $16.3 $853,019 - $1.14 Million	70,092	70,092 $861,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $134M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account